Cellular Origin of Androgen Receptor Pathway-Independent Prostate Cancer and Implications for Therapy  W. Nathaniel Brennen, John T. Isaacs  Cancer Cell 

Slides:



Advertisements
Similar presentations
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Advertisements

Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
Nuclear Receptors, RXR, and the Big Bang Ronald M. Evans, David J. Mangelsdorf Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.
Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem Cells David J. Wong, Helen Liu, Todd W. Ridky, David Cassarino, Eran Segal, Howard.
IPSC Crowdsourcing: A Model for Obtaining Large Panels of Stem Cell Lines for Screening Mahendra Rao Cell Stem Cell Volume 13, Issue 4, Pages (October.
Hedgehog Signaling Restrains Bladder Cancer Progression by Eliciting Stromal Production of Urothelial Differentiation Factors Kunyoo Shin, Agnes Lim, Chen.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities Koen Schepers, Timothy B. Campbell, Emmanuelle Passegué Cell Stem Cell Volume.
Quantitative Single-Cell Approaches to Stem Cell Research Martin Etzrodt, Max Endele, Timm Schroeder Cell Stem Cell Volume 15, Issue 5, Pages (November.
Karl S. Peggs, Neil H. Segal, James P. Allison  Cancer Cell 
Chemotherapy and Cancer Stem Cells
Cancer: Inappropriate Expression of Stem Cell Programs?
Of Brains and Blood: Developmental Origins of Glioma Diversity?
Kristin G. Anderson, Ingunn M. Stromnes, Philip D. Greenberg 
The Tailless Root of Glioma: Cancer Stem Cells
Advances in the Treatment of Metastatic Prostate Cancer
Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
Laetitia Seguin, Sara M. Weis, David A. Cheresh  Cell Stem Cell 
Accelerating drug discovery: Open source cancer cell biology?
Nicole R. Murray, Verline Justilien, Alan P. Fields  Cancer Cell 
An Alternative Sugar Fuels AML
c-Kit as a Novel Potential Therapeutic Target in Colorectal Cancer
The Ids Have It Cancer Cell
Volume 71, Issue 1, Pages 1-3 (January 2017)
Toll-like Receptors Keep Antigen Sorting on the Right Track
Cellular Origin of Androgen Receptor Pathway-Independent Prostate Cancer and Implications for Therapy  W. Nathaniel Brennen, John T. Isaacs  Cancer Cell 
Michael W.M. Kühn, Scott A. Armstrong  Cancer Cell 
Cell signaling and cancer
Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma
MDS Is a Stem Cell Disorder After All
Michael W.M. Kühn, Scott A. Armstrong  Cancer Cell 
Natalia J. Martinez, Richard I. Gregory  Cell Stem Cell 
Volume 26, Issue 1, Pages 1-2 (July 2014)
T.S. Karin Eisinger-Mathason, M. Celeste Simon  Cancer Cell 
The Wind God Promotes Lung Cancer
Daichi Inoue, Omar Abdel-Wahab  Cancer Cell 
Stem Cell Therapies in Clinical Trials: Progress and Challenges
Volume 131, Issue 1, Pages (October 2007)
MicroRNA Regulation of Stem Cell Fate
Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion- Positive Prostate Cancers  Yu Chen, Charles L. Sawyers  Cancer Cell  Volume.
Hopping between Differentiation States in Lung Adenocarcinoma
Gliomas “Dope Up” for Growth
Of Brains and Blood: Developmental Origins of Glioma Diversity?
MicroRNAs and Parallel Stem Cell Lives
The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?
Volume 18, Issue 2, Pages (February 2016)
A Theranostic “SMART” Aptamer for Targeted Therapy of Prostate Cancer
Characterizing the Killer Colorectal Carcinomas
Long-Term Hormonal Therapy: Who Would Benefit?
Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy
Copyright © 2013 Elsevier Inc. All rights reserved.
Bmi1 and Cell of Origin Determinants of Brain Tumor Phenotype
NO Signals from the Cancer Stem Cell Niche
Androgen Receptor Mediated Growth of Prostate (Cancer)
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
William G. Nelson, Michael C. Haffner, Srinivasan Yegnasubramanian 
Volume 14, Issue 4, Pages (October 2008)
A FIRE-y PAGE in the Computational Analysis of Cancer Profiles
Molecular Therapy  Volume 21, Pages S247-S248 (May 2013)
TFIID and MYB Share a Therapeutic Handshake in AML
The Tailless Root of Glioma: Cancer Stem Cells
Attacking Cancer at Its Root
c-Raf in KRas Mutant Cancers: A Moving Target
Is Cyclin D1-CDK4 kinase a bona fide cancer target?
Devyn M. Smith, Emily J. Culme-Seymour, Chris Mason  Cell Stem Cell 
Long Noncoding RNAs in Cancer Pathways
Knocking the Wnt out of the Sails of Leukemia Stem Cell Development
Presentation transcript:

Cellular Origin of Androgen Receptor Pathway-Independent Prostate Cancer and Implications for Therapy  W. Nathaniel Brennen, John T. Isaacs  Cancer Cell  Volume 32, Issue 4, Pages 399-401 (October 2017) DOI: 10.1016/j.ccell.2017.09.011 Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 1 Prostate Cell Lineage, Cancer-Initiating Cells, and Therapeutic Selection Overview of the cellular subtypes within the hierarchically expanding stem cell organization of the normal human prostate epithelial compartment based on the characteristic self-renewal potential, proliferation rate, and phenotypic marker expression. Magnitude of self- renewal potential versus proliferation rate for each subtype is indicated by the number of “+” signs, indicating increasing values, and “−” signs, indicating a zero value. Phenotypic markers are: androgen receptor (AR), prostate-specific antigen (PSA), TP63, and neuroendocrine (NE) genes (i.e., chromogranin A, synaptophysin, etc.), with superscript “+” indicating expression and superscript “−” indicating no expression. Cancer Cell 2017 32, 399-401DOI: (10.1016/j.ccell.2017.09.011) Copyright © 2017 Elsevier Inc. Terms and Conditions